Vetoquinol SA (EPA: VETO)
95.90
+2.90 (3.12%)
Aug 30, 2024, 5:36 PM CET
Vetoquinol Company Description
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses.
The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Vetoquinol SA
![Vetoquinol logo](https://img.stockanalysis.com/logos1/PA/VETO.png)
Country | France |
Founded | 1933 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,440 |
CEO | Matthieu Frechin |
Contact Details
Address: Magny-Vernois Lure, 70204 France | |
Phone | 33 3 84 62 55 55 |
Website | vetoquinol.com |
Stock Details
Ticker Symbol | VETO |
Exchange | Euronext Paris |
Reporting Currency | EUR |
ISIN Number | FR0004186856 |
SIC Code | 2834 |